Insider Holders & Insider Ownership - Bellerophon Therapeutics Inc. (BLPH)

List of insiders holdings for Bellerophon Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Linde North America Inc.
10% Owner		2018-01-02 13:39:018,913,788
0		8,913,788Form 5
VENROCK ASSOCIATES IV L P
Venrock Healthcare Capital Partners III L.P.
VHCP Co-Investment Holdings III LLC
Shah Nimish P
VHCP Management III LLC
10% Owner		2020-02-14 16:05:493,553,583
0		3,553,583Form 13G
VENROCK ASSOCIATES IV L P
VENROCK ENTREPRENEURS FUND IV L P
VEF Management IV LLC
Koh Bong Y
Venrock Healthcare Capital Partners II L.P.
Venrock Management IV LLC
Venrock Partners Management LLC
Venrock Partners L.P.
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
10% Owner		2020-02-14 16:05:493,553,583
0		3,553,583Form 13G
Puissance Capital Management LP
Puissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Wang Theodore T
10% Owner		2023-10-17 21:05:121,211,262
0		1,211,262Form 13D
Puissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner		2023-10-17 21:05:121,211,262
0		1,211,262Form 13D
NELSEN ROBERT
Director
10% Owner		2015-02-23 21:47:590
965,660		965,660Form 4
Edmonds Amy
VP Clinical Operations & Admin		2019-09-30 16:39:40445,886
0		445,886Form 4
Tenenbaum Fabian
Chief Executive Officer		2019-11-19 16:36:08407,459
0		407,459Form 4
Amin Naseem
Director		2023-06-09 16:12:24291,865
0		291,865Form 4
Tasse Daniel
Director		2018-06-25 16:33:08182,604
0		182,604Form 4
Peacock Jonathan M
Director		2021-04-02 16:10:16157,033
0		157,033Form 4
Agrawal Amit
Chief Operating Officer		2015-07-13 06:50:52100,000
0		100,000Form 4
Fernandes Peter
See Remarks		2023-06-09 16:12:06100,000
0		100,000Form 4
Luehring Jens
Director		2018-06-25 16:32:3995,213
0		95,213Form 4
Quinn Deborah
Chief Medical Officer		2018-06-14 16:42:5594,070
0		94,070Form 4
Korner Assaf
CFO		2019-11-19 16:35:2966,078
0		66,078Form 4
Puissance Cross-Border Opportunities III LLC
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner		2020-05-22 06:46:1653,327
0		53,327Form 13D
Dekker Martin
See Remarks		2023-06-09 16:11:2950,000
0		50,000Form 4
Kim Bobae
VP Reg. Affairs & Quality		2023-06-09 16:10:5550,000
0		50,000Form 4
Laccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)		2023-02-14 16:46:1350,000
0		50,000Form 4
Shah Parag Suresh
VP of Business Operations		2023-06-09 16:11:5050,000
0		50,000Form 4
FARES Wassim
Chief Medical Officer		2020-09-14 16:04:1730,000
0		30,000Form 4
Huennekens R Scott
Director		2015-05-14 19:37:0525,000
0		25,000Form 4
Schoeps Megan
Principal Financial Officer		2017-12-13 16:36:2922,248
0		22,248Form 4
MEGLASSON MARTIN
Chief Scientific Officer		2015-05-22 07:32:5419,098
0		19,098Form 4
Teufel Crispin
Director		2023-06-09 16:10:0914,607
0		14,607Form 4
Cloyd Mary Ann
Director		2023-06-09 16:10:2214,607
0		14,607Form 4
Bruder Scott P
Director		2023-06-09 16:11:1414,607
0		14,607Form 4
Moura Andre V.
Director		2020-09-14 16:03:2813,472
0		13,472Form 4
Abrams David
Treasurer		2015-12-03 17:17:5913,116
0		13,116Form 4
Holt Matthew S.
Director
10% Owner		2016-06-21 18:21:0410000
0		10000Form 4
Weinstein Adam
Director
10% Owner		2017-09-26 16:53:1510000
0		10000Form 4
Heyrman Reinilde
Chief Clinical Dev. Officer		2015-03-16 17:06:279909
0		9909Form 4
BENNETT MATTHEW
Director		2020-09-14 16:03:126509
0		6509Form 4
Naidu Manesh
Chief Business Officer		2015-03-16 17:03:284892
0		4892Form 4
ARCH VENTURE FUND VI LP
ARCH VENTURE PARTNERS VI LP
ARCH VENTURE PARTNERS VI LLC
CRANDELL KEITH
BYBEE CLINTON
10% Owner		2017-01-04 13:45:360
0		0Form 13D
New Mountain Investments II LLC
New Mountain Capital L.L.C.
KLINSKY STEVEN B
10% Owner		2022-02-14 10:45:440
0		0Form 13G
New Mountain Investments II LLC
Allegheny New Mountain Partners L P
New Mountain Affiliated Investors II LP
New Mountain Capital L.L.C.
New Mountain Partners II (AIV-A) L.P.
New Mountain Partners II (AIV-B) L.P.
New Mountain Partners II Special (AIV-A) LP
KLINSKY STEVEN B
10% Owner		2022-02-14 10:45:440
0		0Form 13G